Cita APA

Juanola Mayos, A., Graupera, I., Elia, C., Piano, S., Solé, C., Carol, M., . . . Ginès i Gibert, P. (2022). Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis.

Citación estilo Chicago

Juanola Mayos, Adrià, et al. Urinary L-FABP Is a Promising Prognostic Biomarker of ACLF and Mortality in Patients With Decompensated Cirrhosis. 2022.

Cita MLA

Juanola Mayos, Adrià, et al. Urinary L-FABP Is a Promising Prognostic Biomarker of ACLF and Mortality in Patients With Decompensated Cirrhosis. 2022.